Carbimazole

Derazantinib(ARQ-087) is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3, showing lower potency for FGFR4 (IC50=34 nM). It also inhibits RET, DDR2,

Derazantinib(ARQ-087) is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3, showing lower potency for FGFR4 (IC50=34 nM). It also inhibits RET, DDR2,

Ethyl 1-(pyrazin-2-yl)-1H-pyrazole-4-carboxylate.

Ethyl 1-(pyrazin-2-yl)-1H-pyrazole-4-carboxylate.

Ethyl 1-(pyrazin-2-yl)-1H-pyrazole-4-carboxylate.

Ethyl 1-(pyrazin-2-yl)-1H-pyrazole-4-carboxylate.

ethyl 3-amino-1H-pyrazole-5-carboxylate

ethyl 4-​amino-​1-​methyl-​pyrazole-​3-​carboxylate.

ethyl 4-hydroxy-1-phenyl-1H-pyrazole-3-carboxylate.

ethyl 4-hydroxy-1-phenyl-1H-pyrazole-3-carboxylate.

ethyl 4-iodo-1H-pyrazole-3-carboxylate.

ethyl 4-iodo-1H-pyrazole-3-carboxylate.